The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision

Background: The metastatic site seems to represent a malignancy with a different biological characteristic and is an important prognostic factor in metastatic pancreatic ductal adenocarcinoma (mPDAC). Palliative radiotherapy is a therapeutic option, and usually used for pain management in the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Biaoxiang, Zhou, Yuan, Pei, Qian, Tan, Fengbo, Zhao, Lilan, Güngör, Cenap, Wang, Dan, Li, Yuqiang, Liu, Wenxue, Zhou, Zhongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771529/
https://www.ncbi.nlm.nih.gov/pubmed/35069888
http://dx.doi.org/10.7150/jca.64800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771529/
https://www.ncbi.nlm.nih.gov/pubmed/35069888
http://dx.doi.org/10.7150/jca.64800

Ejemplares similares